Javier P Gisbert Selected Research

Adalimumab (Humira)

1/2024	Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
8/2023	Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.
1/2023	Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
11/2020	Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
6/2020	Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice.
1/2020	Response to the Letter to the Editor: "Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease".
10/2019	Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
1/2019	Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial.
1/2019	Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial.
10/2017	Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn's Disease Recurrence. A GETECCU Randomised Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier P Gisbert Research Topics

Disease

96	Crohn Disease (Crohn's Disease) 02/2024 - 02/2004
96	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 03/2002
74	Ulcerative Colitis 05/2024 - 02/2004
62	Infections 12/2023 - 03/2002
17	Necrosis 09/2023 - 05/2010
13	Dyspepsia (Indigestion) 04/2024 - 01/2004
9	Peptic Ulcer (Peptic Ulcers) 03/2022 - 02/2002
9	Anemia 01/2022 - 05/2008
9	Hemorrhage 01/2022 - 02/2004
9	Ulcer 12/2020 - 06/2003
8	Neoplasms (Cancer) 03/2023 - 09/2011
8	Inflammation (Inflammations) 12/2022 - 08/2006
7	Iron Deficiencies 01/2022 - 05/2008
7	Stomach Neoplasms (Stomach Cancer) 06/2021 - 02/2003
6	Fistula 07/2023 - 04/2012
6	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022 - 06/2012
6	Colitis 01/2022 - 06/2011
5	Hypersensitivity (Allergy) 10/2023 - 07/2007
4	Lymphoma (Lymphomas) 03/2023 - 05/2015
4	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 05/2007
4	Gastroesophageal Reflux (GERD) 05/2012 - 05/2005
4	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2010 - 05/2008
3	COVID-19 01/2024 - 10/2020
3	Tuberculosis (Tuberculoses) 06/2023 - 10/2008
3	Pathologic Constriction (Stenosis) 01/2023 - 05/2020
3	Psoriatic Arthritis 01/2021 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2016
3	Hepatitis B 11/2020 - 03/2013
3	Colorectal Neoplasms (Colorectal Cancer) 03/2016 - 05/2006
2	Pancreatitis 03/2024 - 09/2020
2	Disease Progression 02/2024 - 08/2011
2	Abscess 11/2023 - 08/2012
2	Thrombosis (Thrombus) 01/2023 - 08/2022
2	Pulmonary Embolism 01/2023 - 01/2022
2	Arthritis (Polyarthritis) 02/2022 - 02/2013
2	Body Weight (Weight, Body) 12/2021 - 11/2009
2	Celiac Disease (Celiac Sprue) 12/2020 - 07/2015

Drug/Important Bio-Agent (IBA)

33	Infliximab (Remicade)FDA Link 03/2024 - 08/2008
22	Adalimumab (Humira)FDA Link 01/2024 - 05/2010
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 10/2008
20	Ustekinumab (CNTO 1275)FDA Link 02/2024 - 01/2016
19	Azathioprine (Imuran)FDA LinkGeneric 01/2019 - 06/2003
17	2-mercaptopurineIBA 03/2024 - 11/2006
15	SteroidsIBA 02/2024 - 06/2003
15	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2007
15	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2005
15	vedolizumabIBA 09/2023 - 05/2015
11	Immunologic Factors (Immunomodulators)IBA 03/2023 - 01/2010
11	IronIBA 01/2022 - 05/2008
11	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2018 - 06/2003
10	Proton Pump InhibitorsIBA 12/2023 - 05/2005
10	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023 - 01/2010
10	Clarithromycin (Biaxin)FDA LinkGeneric 08/2021 - 09/2005
7	BismuthIBA 04/2024 - 01/2012
7	tofacitinibIBA 03/2024 - 06/2019
7	Methotrexate (Mexate)FDA LinkGeneric 02/2024 - 05/2011
7	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 11/2002
7	Amoxicillin (Wymox)FDA LinkGeneric 01/2020 - 09/2005
7	UreaseIBA 11/2019 - 03/2002
7	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2018 - 03/2007
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2024 - 05/2010
6	Mesalamine (Mesalazine)FDA LinkGeneric 01/2024 - 03/2002
6	AntibodiesIBA 01/2024 - 07/2011
6	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 12/2006 - 06/2003
5	VaccinesIBA 06/2023 - 03/2013
5	Metronidazole (Metric)FDA LinkGeneric 08/2021 - 07/2013
5	CytokinesIBA 10/2019 - 08/2006
5	Erythropoietin FDA Link 11/2013 - 05/2008
5	Omeprazole (Prilosec)FDA LinkGeneric 07/2013 - 01/2005
4	golimumab FDA Link 10/2023 - 06/2016
4	Biosimilar PharmaceuticalsIBA 07/2023 - 06/2018
4	IntegrinsIBA 01/2023 - 06/2016
4	AntigensIBA 08/2022 - 08/2004
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 02/2002
4	Levofloxacin (Levaquin)FDA Link 08/2021 - 02/2013
4	Monoclonal AntibodiesIBA 10/2020 - 05/2010
3	Tumor Necrosis FactorsIBA 01/2024 - 03/2013
3	Phenobarbital (Luminal)FDA Link 11/2023 - 11/2009
3	Penicillins (Penicillin)FDA Link 10/2023 - 02/2015
3	Rifabutin (Ansamycin)FDA Link 03/2022 - 12/2020
3	AlbuminsIBA 12/2021 - 12/2014
3	Tetracycline (Achromycin)FDA LinkGeneric 08/2021 - 10/2020
3	Immunomodulating AgentsIBA 01/2021 - 01/2016
3	Peptides (Polypeptides)IBA 12/2020 - 10/2019
3	Urea (Carbamide)FDA LinkGeneric 08/2020 - 01/2003
3	Tuberculin (PPD)IBA 11/2018 - 09/2013
3	Esomeprazole (Nexium)FDA Link 09/2017 - 01/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 08/2006
3	Ferritins (Ferritin)IBA 11/2013 - 05/2008
3	NitroimidazolesIBA 07/2013 - 01/2012
2	COVID-19 VaccinesIBA 01/2024 - 11/2023
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 07/2015
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2009
2	Dextran SulfateIBA 01/2022 - 03/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 12/2021 - 11/2013
2	Capsules (Microcapsules)IBA 01/2021 - 10/2020

Therapy/Procedure

114	Therapeutics 05/2024 - 06/2003
9	Biological Therapy 11/2023 - 05/2010
4	Colectomy 03/2024 - 09/2008
4	Aftercare (After-Treatment) 03/2013 - 03/2002